Advertisement
Australia markets close in 2 hours 27 minutes

  • ALL ORDS

    7,910.10
    +49.10 (+0.62%)
     

  • ASX 200

    7,654.40
    +48.80 (+0.64%)
     

  • AUD/USD

    0.6451
    +0.0014 (+0.22%)
     

  • OIL

    82.90
    +0.21 (+0.25%)
     

  • GOLD

    2,389.20
    +0.80 (+0.03%)
     

  • Bitcoin AUD

    96,280.87
    -2,888.28 (-2.91%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • AUD/EUR

    0.6038
    +0.0012 (+0.20%)
     

  • AUD/NZD

    1.0886
    +0.0013 (+0.12%)
     

  • NZX 50

    11,803.71
    -71.64 (-0.60%)
     

  • NASDAQ

    17,493.62
    -220.04 (-1.24%)
     

  • FTSE

    7,847.99
    +27.63 (+0.35%)
     

  • Dow Jones

    37,753.31
    -45.66 (-0.12%)
     

  • DAX

    17,770.02
    +3.79 (+0.02%)
     

  • Hang Seng

    16,451.06
    +199.22 (+1.23%)
     

  • NIKKEI 225

    38,090.87
    +129.07 (+0.34%)
     

Theratechnologies to Present at the Bloom Burton & Co. Healthcare Investor Conference

Theratechnologies
·1-min read

MONTREAL, April 12, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer will present at the Bloom Burton & Co. Healthcare Investor Conference on Wednesday, April 21, 2021 at 10:30 a.m. ET.

The live webcast will be available at https://wsw.com/webcast/bloomburton6/thtx/. The live and archived webcast link will also be available in the ‘News’ section of the Company’s website.

About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov

For media inquiries:
Denis Boucher
Vice-President, Communications and Corporate Affairs
514-336-7800

For investor inquiries:
Leah Gibson
Senior Director, Investor Relations
ir@theratech.com
617-356-1009